We launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country. Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.
The team started by screening HIV patients at the hospital for co-infection; today teams have expanded screening to include patients referred by Preah Kossamak hospital’s hepatology department.
Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.
MSF teams responded to the coronavirus COVID-19 pandemic in the country between February and June 2020, in which training and technical support was provided in six hospitals.
Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study
![Cambodia Active Case Finding Pilot Program Cambodia Active Case Finding Pilot Program](https://img.msf.org/Docs/MSF/Media/CMS3/f/3/e/a/MSB7943.jpg)
Cambodia wasn’t initially on Helen Tindall’s radar ...
Spatial epidemiology and climatic predictors of paediatric dengue infections captured via sentinel site surveillance, Phnom Penh Cambodia 2011-2012
![Cambodia Active Case Finding Pilot Program Cambodia Active Case Finding Pilot Program](https://img.msf.org/Docs/MSF/Media/CMS3/1/f/1/a/MSB7933.jpg)
Active Case Finding in Cambodia: Searching for TB one village at a time
Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia
![](/themes/custom/msf_theme/src/kss/components/image/assets/placeholder.jpg)